3billion Presents GEBRA™ SaaS Implementation and Global Expansion at AWS HealthTech Seminar

3billion Shares GEBRA™ SaaS Implementation and Global Expansion Story at ‘HealthTech Global Expansion Seminar 2026’

On April 28, 3billion participated as a speaker at the ‘HealthTech Global Expansion Seminar 2026’ hosted by Amazon Web Services (AWS), where the company shared its experience in building the SaaS platform for GEBRA—its AI-powered genetic variant interpretation software—and its journey into the global market. The seminar was designed to provide healthcare companies targeting international markets with practical know-how on technical implementation and service scalability.

During the session, Taehwa Yoon from 3billion’s SW Group detailed the global expansion process of GEBRA, which integrates the company’s proprietary AI genetic variant interpretation technology. A key highlight of the presentation was the technical response strategy developed in collaboration with AWS to meet HIPAA (Health Insurance Portability and Accountability Act) compliance, a critical global security standard for processing medical data. By leveraging AWS’s robust cloud security tools, 3billion successfully addressed varying data governance requirements across different countries and established a cloud-native environment capable of processing large-scale genomic data securely and efficiently worldwide.

Beyond just launching a SaaS product, the presentation provided deep insights for developers and industry professionals by sharing a vivid account of how the company overcame real-world technical challenges encountered in the global medical field. Moving forward, 3billion plans to combine its advanced AI genetic variant interpretation technology with a stable SaaS infrastructure to solidify its position as a global leader in AI genetic diagnostics, providing the fastest and most accurate diagnostic solutions for rare disease patients worldwide.